On (b)(6) 2017, a 23 mm biocor valve was implanted in a (b)(6) year-old female with severe calcific aortic stenosis (ppg/mpg - 192/115 mmhg) as part of a concomitant cabg and vsd closure.The procedure was uneventful but prolonged due to multiple procedural steps.On (b)(6) 2017, an echocardiogram showed good prosthetic valve function with acceptable gradients across the valve and normal lv function.However, a few days after, the patient was breathless, not mobilizing and noted to have a left pleural effusion which required drainage.An echo performed on (b)(6) 2017 showed severely increased gradients (108/53 mmhg) with suspicion of a membrane below the valve.A tee was performed and confirmed the higher gradients and an immobile left cusp.On (b)(6) 2017, the valve was explanted and replaced with a 25 mm regent heart valve.During explant, the native tissue was fragile and the annulus was completely destroyed which led to a root replacement.Per report, on 02 july 2017, the patient died due to low cardiac output, renal failure and bleeding after post-cardiotomy.
|
The results of this investigation concluded there was fungal endocarditis in the returned 23 mm biocor valve.All three cusps contained vegetations with numerous fungal organisms and marked inflammation.All three cusps were fibrotically thickened and contained inflow and outflow thrombus.There was no significant calcifications present in the valve.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.There was no evidence found to suggest the cause of the fungal endocarditis, fibrin, or thrombus were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
|